GenixCure

뉴스&공지

뉴스&공지

뉴스

KISTI Selects GENIXCURE as Lead Company for AI-Based Gene Therapy Development Platform

2024-11-15
SME Technology Innovation Project Selects 'Market Expansion' Task to Drive Growth

2024-11-12
Presented ‘Engineering Next-Generation AAV Vectors for Enhanced ALS Therapy’ at SfN 2024

2024-10-22
Awarded at ‘G-Star Audition Scale-Up’ Global Startup IR Competition

2024-10-22
'Korea Investment Week 2024' Participation

2024-09-23
Signed a MOU with Modalis Therapeutics Corporation, jointly developing a XOB031-mediated AAV gene therapy for Alzheimer’s disease

2024-07-12
GXC-301 ODD request granted by US FDA

2024-07-02
GENIXCURE, Selected as a ‘2024 Global Unicorn’

2024-06-26
GXC-301 RPDD request granted by US FDA

2024-05-31